Olumide B. Gbolahan, MBBS, MSc

• A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors

  • Phase

    I/II
  • Conditions

    Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, KRAS G12D, KRAS G12R, KRAS G12V, KRAS G12A, KRAS G12C, KRAS G12S, KRAS G13D, NRAS G12D, NRAS G12R, NRAS G12V, NRAS G12C, NRAS G12S
  • Location

    Emory University Hospital Midtown, Winship Cancer Institute

• Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

  • Phase

    I/II
  • Conditions

    Cholangiocarcinoma, Gallbladder Carcinoma, Stage III Gallbladder Cancer AJCC v8, Stage III Hilar Cholangiocarcinoma AJCC v8, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IV Gallbladder Cancer AJCC v8, Stage IV Hilar Cholangiocarcinoma AJCC v8, Stage IV Intrahepatic Cholangiocarcinoma AJCC v8
  • Location

    Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Winship Cancer Institute

• Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

  • Phase

    III
  • Conditions

    Biliary Tract Cancer, HER2 Gene Mutation
  • Location

    Winship Cancer Institute

• Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

  • Phase

    III
  • Conditions

    Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver, Stage IV Colorectal Cancer AJCC v8, Unresectable Colorectal Carcinoma
  • Location

    Winship Cancer Institute

• A Study of ASP1012 in Adults With Solid Tumors

  • Phase

    I
  • Conditions

    Solid Tumor
  • Location

    Winship Cancer Institute

• A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (IMbrave152)

  • Phase

    III
  • Conditions

    Carcinoma, Hepatocellular
  • Location

    Emory University Hospital Midtown, Winship Cancer Institute

• A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

  • Phase

    III
  • Conditions

    Colorectal Neoplasms
  • Location

    Emory University Hospital Midtown, Winship Cancer Institute, Grady Health System

• Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer

  • Phase

    II
  • Conditions

    Stage IB Hepatocellular Carcinoma AJCC v8, Stage II Hepatocellular Carcinoma AJCC v8, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8
  • Location

    Emory University Hospital Midtown, Winship Cancer Institute

• Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • Phase

    II
  • Conditions

    Recurrent Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8, Stage IVA Hepatocellular Carcinoma AJCC v8, Stage IVB Hepatocellular Carcinoma AJCC v8, Unresectable Hepatocellular Carcinoma
  • Location

    Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Winship Cancer Institute

• A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)

  • Phase

    I/II
  • Conditions

    Solid Tumours Harboring NRG1 Fusion, NSCLC Harboring NRG1 Fusion, Pancreatic Cancer Harboring NRG1 Fusion, NRG1 Fusion
  • Location

    Winship Cancer Institute

• 2 Versus 6 Hour Oxaliplatin Infusions in Patients with Gastrointestinal Cancers

  • Phase

    II
  • Conditions

    Malignant Digestive System Neoplasm
  • Location

    Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Winship Cancer Institute

A pilot study of the immune microenvironment of GI neuroendocrine carcinoma.

Endocrine-related cancer

Adjuvant Chemotherapy and Outcomes in Older Adult Patients With Biliary Tract Cancer.

JAMA network open

Safety and Efficacy of Concurrent Atezolizumab/Bevacizumab or Nivolumab Combination Therapy with Yttrium-90 Radioembolization of Advanced Unresectable Hepatocellular Carcinoma.

Current oncology (Toronto, Ont.)

Role of chemoradiation in gallbladder cancer-a single institution retrospective analysis.

Journal of gastrointestinal oncology

Outcomes of responders to PD-1/PD-L1 inhibitors who discontinue therapy after sustained disease control.

Journal of cancer research and clinical oncology

Are Lymph Node Metastases Associated With Survival in Black Patients With Pancreatic Cancer?

The Journal of surgical research

Time to treatment initiation and its impact on real-world survival in metastatic colorectal cancer and pancreatic cancer.

Cancer medicine

Short- and Long-Term Survival of Metastatic Biliary Tract Cancer in the United States From 2000 to 2018.

Cancer control : journal of the Moffitt Cancer Center

Patient-reported geriatric assessment-based frailty index among older adults with gastrointestinal malignancies.

Journal of the American Geriatrics Society

Differences in Pretreatment Frailty Across Gastrointestinal Cancers in Older Adults: Results From the Cancer and Aging Resilience Evaluation Registry.

JCO oncology practice

Does race affect the long-term survival benefit of systemic therapy in pancreatic adenocarcinoma?

American journal of surgery

Geriatric Assessment Predictors of 1-Year Mortality in Older Adults With GI Malignancies: A Survival Tree Analysis.

JCO clinical cancer informatics

11/03/2024

Dr. Gbolahan is amazing. He listens and is great in sharing information. He is always concerned about me as the pt and my wife who is the primary care taker.

11/02/2024

I loved Dr. Gbolihan!!

09/26/2024

Dr Gbolahan was very caring, knowledgeable, & informative. He clarified everything & gave me options. He mentioned I'd be cared for by another doctor when I return for a follow up. I wish him well.

09/25/2024

Dr. Olu patiently answered all my questions and gave me his perspective on my current condition.

08/15/2024

Good

08/09/2024

Dr Gbolahan did a fantastic job

05/25/2024

Dr. B is awesome explain everything in detail, listen to you, and take the necessary time with you.

05/23/2024

If they are diagnosed with cancer this is the only hospital that I would ever refer them toI.

05/06/2024

Dr. Gbolahan and his entire team are the BEST! He takes time to address all of our concerns. He reviewed my father's charts in detail before he met with us and heard our concerns. Because my father's situation is complex/multiple issues, he and his team looked at his situation from all angles and based his treatment and care from that. Different from past experiences where we felt like a part of a standard assembly line. He takes extra measure to go above and beyond. Because he looked at the WHOLE picture, and not through a single oncologist lens, my father is feeling better than he has in 6 mos. We Thank you!

05/03/2024

Fantastic job

04/25/2024

We really like Dr Gblobohon our only complaint is the excessive delays

03/15/2024

They are very interested in what's going on with any of my wants concerns and needs I if I have any problems or concerns they address them right away.

03/08/2024

Good experience

03/08/2024

Extremely very good..

01/31/2024

We praise God for all staff. Everyone goes that extra mile. My ratings is 100

01/17/2024

The doctor showed compassion and professionalism as we talked. He asked questions to discern my understanding.

12/15/2023

The doctor was a great listener and his compassion was amazing!

12/06/2023

Very professional and seeking to know I understood the situation and decision making needed.

11/02/2023

Dr. Gbolahan was a very good, compassionate listener. He clearly explained my situation and referred me to appropriate doctors for follow up.

11/01/2023

Always professional , courteous, and caring and making sure I understand.

11/01/2023

Excellent communication, JOB WELL DONE!

10/21/2023

Good experience

09/22/2023

This was my time time meeting Dr Gbolohan. He was very compassionate to my condition.

09/14/2023

Even though I am new to these treatments the doctor made sure I understood what they were and how they will work

09/08/2023

Christie was an Angel in human form! We needed her! Amazing! Really cared! Calming effect.

08/31/2023

Excellent suggestions provided that I could do myself. Also provided me with a new script to help me in one area of concern.

08/30/2023

Excellent

08/26/2023

First time seeing this dr but he seemed familiar with my case and working on options prior dr had discussed

08/18/2023

Always personal!

08/09/2023

My doctor alleviated my concerns. I am not feeling as hopeless as I was prior to our visit.

08/02/2023

Dr Gbolahan seems extremely knowledgeable. He was easy to talk to and understand. He even allowed my husband and sister to participate in the call.

07/20/2023

The doctor was very kind and professional...gave a lot of care how he expressed his interest in my husband's case...

07/08/2023

Good experience

07/06/2023

The doctor have too many patients for him to be there once a week.

06/28/2023

Excellent video visit. Questions were answered & fully understood the next step.

06/20/2023

A knowleageable young and caring doctor with nice and professional team second to none.

06/13/2023

The care providers are very nice to people .

05/27/2023

Good experience

05/19/2023

Good experience

05/17/2023

Such care expressed was encouraging.

04/20/2023

Dr Gbolahan is a very compassionate person with real attention to my health.

04/05/2023

New Doctor to me. Always helpful and answers my questions

02/11/2023

Dr. Gbolahan seems to be a very knowledgeable physician. He answered all of questions and was very patient. He explained to me my treatment and outcome thoroughly. He apologized for the time that we spent waiting at the office. He is the third oncologist that I have seen as the other two have left Emory. I saw the first one only once and never saw the second one. Only PAs handled my care for the last 4 years. Hopefully Dr. Gbolahan will be able to participate more and look forward to my visits because if his knowledge and positive attitude.

01/06/2023

No bad experiences. In my case, all have been as good as possible given the work load on those providing care.